Search

everythinglearnresearchcommunity

for

Search:↓

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Some breast cancer chemotherapy can cause permanent hair loss.

Menopause significantly affects skin health and conditions.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Female hair loss patients more likely to have dry eye and gland issues.

Both genetic and lifestyle factors significantly affect female hair loss.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Taking biotin can lead to incorrect low results in free testosterone tests.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.